Cancer Research · 2010 · 77 citations · 36 references
MedicineImmunologyOncologyCancer ImmunologyImmunotherapyTumor ImmunologyAdaptive Immune ResponsesAntitumor T Cell ResponsesCancer ImmunotherapyCancer VaccinesCell-mediated ImmunityImmunotherapy For Skin CancerAdaptive Antitumor ImmunityAntitumor Immune ActivationAntitumor Immune MemoryMelanoma ImmunotherapyPeptide VaccinationT-cell Responses To Tumor AntigensTumor ReactivityTumor-specific T Cell Clones
Combination of chemotherapy and immunotherapy to increase the effectiveness of an antitumor immune response is currently regarded as an attractive antitumor strategy. In a pilot clinical trial, we have recently documented an increase of melanoma antigen A (Melan-A)-specific, tumor-reactive, long-lasting effector-memory CD8(+) T cells after the administration of dacarbazine (DTIC) 1 day before peptide vaccination in melanoma patients. Global transcriptional analysis revealed a DTIC-induced activation of genes involved in the immune response and leukocyte activation. To identify the possible mechanisms underlying this improved immune response, we have compared the endogenous and the treatment-induced anti-Melan-A response at the clonal level in patients treated with the vaccine alone or with DTIC plus vaccine. We report a progressive widening of T-cell receptor (TCR) repertoire diversity, accompanied by high avidity and tumor reactivity, only in Melan-A-specific T-cell clones of patients treated with chemoimmunotherapy, with a trend toward longer survival. Differently, patients treated with vaccine alone showed a tendency to narrowing the TCR repertoire diversity, accompanied by a decrease of tumor lytic activity in one patient. Collectively, our findings indicate that DTIC plus vaccination shapes the TCR repertoire in terms of diversity and antitumor response, suggesting that this combined therapy could be effective in preventing melanoma relapse.
36
Cancer immunotherapy: moving beyond current vaccines
Steven A. Rosenberg, James C. Yang, Nicholas P. Restifo · Nature Medicine · 2004 · 3K citations · Full text
Medicine, Immunology, Oncology +14
Jorge R. Almeida, David A. Price, Laura Papagno et al. · The Journal of Experimental Medicine · 2007 · 715 citations · Full text